Home Log In
Tuesday, October 6, 2026
28.3
C
Bengaluru
Hot topics
Digital Therapeutics: New Frontiers in Healthcare
“If we look at major trends, people are living longer, on average, so there’s a rise in chronic diseases associated with aging. Meanwhile, healthcare workers are in short supply, and physicians and nurses do not have enough time for patients. Yet everyone has powerful computers in their pockets that give them access to technology, education, and information. Put all that together, and it’s the perfect moment for digital solutions to come to the market, change behavior, and enhance health outcomes at scale”
- Bozidar Jovicevic, Global head of Digital Therapeutics, Sanofi
Don’t Do Digital for the Sake of Doing Digital
Catalyzed by the pandemic, the pharma industry quickly progressed from being digitally agnostic to a state of preparedness.
The shift required the industry to experiment with technology in its customer-facing plans, which resulted in many cases the creation of random acts of digital, often without a cohesive overarching strategy.
Can pharma do better? The answer lies in understanding the utility of their digital assets while building a mindset to transform, and ensuring that teams within the organization do not work at cross-purposes.
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
How To See Dr Reddy’s Nestle In The Wellness Shift
GLP-1 medicines such as semaglutide and tirzepatide are changing...
Indian Pharma Is Two Industries Wearing One Label
Indian pharma is often discussed as one sector. In...
Why Is the World’s Pharmacy Failing to Protect Patients from Harm?
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.
With over three decades of experience in the pharmaceutical...
The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?
India’s anaemia challenge is not simply about access to...
10 Years of Pharma M&A — Who’s Really Benefited?
Pharmaceutical M&A is usually discussed in the language of...
Indian Pharma Is Two Industries Wearing One Label
Indian pharma is often discussed as one sector. In...
Why Is the World’s Pharmacy Failing to Protect Patients from Harm?
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.
With over three decades of experience in the pharmaceutical...
The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?
India’s anaemia challenge is not simply about access to...
10 Years of Pharma M&A — Who’s Really Benefited?
Pharmaceutical M&A is usually discussed in the language of...
Indian Pharma Is Two Industries Wearing One Label
Indian pharma is often discussed as one sector. In...
Why Is the World’s Pharmacy Failing to Protect Patients from Harm?
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.
With over three decades of experience in the pharmaceutical...
The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?
India’s anaemia challenge is not simply about access to...
10 Years of Pharma M&A — Who’s Really Benefited?
Pharmaceutical M&A is usually discussed in the language of...
Indian Pharma Is Two Industries Wearing One Label
Indian pharma is often discussed as one sector. In...
Why Is the World’s Pharmacy Failing to Protect Patients from Harm?
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.
With over three decades of experience in the pharmaceutical...
The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?
India’s anaemia challenge is not simply about access to...
10 Years of Pharma M&A — Who’s Really Benefited?
Pharmaceutical M&A is usually discussed in the language of...
Hot topics
Digital in Pharma and RoI – What and How to Measure Metrics that Matter
To be able to measure the RoI on digital in pharma, it is necessary to understand customers as individuals and create newer segmentation based on these needs and interests. This calls for the NextGen RCPA of data collection and personalized communications that engage customers, based on which pharma must create customer experiences that matter to them.
If your content does not scratch, where it itches the customers, digital or phygital, customers will not feel at home (comfortable, delighted, and wants more), which is what matters. Not a digital euphoria, which will soon die down as customers simply ignore it as they did when pharma launched a plethora of webinars.
What Exactly Does Going Digital Mean?
Going digital is not about Social media or Omni channels. Is it about asking simple questions.
Best Buy is one of the largest electronic good retailers in USA. Few years ago Best Buy was threatened by what is now known as Showrooming effect. Basically customers would walk into its showrooms get benefitted by the advice of the salesperson, decide on the model and then go online to buy the product on Amazon because of low prices. Despite having one the best footfalls in the decade Best Buy recorded reduced profits. Although it did try to Price match Amazon they knew it was not a long-term solution because of its cost structure (Physical showrooms, salespeople etc). They couldn’t block the customers from checking price of product on Amazon. Future looked uncertain, everyone thought game over for Best Buy which was the case with many other retailing giants. No amount of investing new technology would have helped Best Buy .
Best Buy relearned how to make profits. Best Buy proposed to the manufacturers that they compensate Best Buy for exclusive showcasing of manufacturers new products. Manufacturers also could launch specific brand kiosks within Best Buy showroom for a fee. This new model which had zero investment for Best Buy dramatically increased its profitability.
Is this a ground breaking innovation? Of course NO. This has already been practiced in other industries but for the first time tried in Electronic good Retail. Best Buy realized apart from consumers it created lot of value for manufacturers therefore it captured the value lost from consumers from manufacturers.
What is my business? What is my business ecosystem? How do I currently make money? How changing one thing impacts my ecosystem? What are the options available?
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
IMS Health Market Reflection Report for September 2016
The Indian Pharmaceutical Market (IPM) was valued at Rs. 10,278 crs in the month of September 2016 clocking a strong 10% growth over same period last year (SPLY). On a MAT September basis, the industry was valued at Rs. 111,022 crores and reflected a 13% growth with volumes contributing around 40% of this growth and New Introductions playing an important role with around 38% contribution to the overall growth.
Key Challenges Facing Indian Pharma
With the Second Wave hitting India, customers (patients and physicians) will continue to socially distance themselves in the foreseeable future. Pharma must use the field force for reach and relationship and digital for frequency and personalised content for better customer experience.
The pandemic has made doctors adopt Telehealth in a substantial way to shore up their revenues and this will continue to be one of their channels to engage patients. Telehealth along with EMR/EHR, digital therapeutics and wearables is enabling doctors to better care for their patients. There are many ways in which pharma can support the digital evolution of doctors.
Indian Pharma Is Two Industries Wearing One Label
Indian pharma is often discussed as one sector. In...
Why Is the World’s Pharmacy Failing to Protect Patients from Harm?
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.
With over three decades of experience in the pharmaceutical...
The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?
India’s anaemia challenge is not simply about access to...
10 Years of Pharma M&A — Who’s Really Benefited?
Pharmaceutical M&A is usually discussed in the language of...
Indian Pharma Is Two Industries Wearing One Label
Indian pharma is often discussed as one sector. In...
Why Is the World’s Pharmacy Failing to Protect Patients from Harm?
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.
With over three decades of experience in the pharmaceutical...
The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?
India’s anaemia challenge is not simply about access to...
10 Years of Pharma M&A — Who’s Really Benefited?
Pharmaceutical M&A is usually discussed in the language of...
Indian Pharma Is Two Industries Wearing One Label
Indian pharma is often discussed as one sector. In...
Why Is the World’s Pharmacy Failing to Protect Patients from Harm?
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.
With over three decades of experience in the pharmaceutical...
The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?
India’s anaemia challenge is not simply about access to...
10 Years of Pharma M&A — Who’s Really Benefited?
Pharmaceutical M&A is usually discussed in the language of...
Indian Pharma Is Two Industries Wearing One Label
Indian pharma is often discussed as one sector. In...
Why Is the World’s Pharmacy Failing to Protect Patients from Harm?
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.
With over three decades of experience in the pharmaceutical...
The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?
India’s anaemia challenge is not simply about access to...
10 Years of Pharma M&A — Who’s Really Benefited?
Pharmaceutical M&A is usually discussed in the language of...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
Indian Pharma Is Two Industries Wearing One Label
Indian pharma is often discussed as one sector. In...
Why Is the World’s Pharmacy Failing to Protect Patients from Harm?
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.
With over three decades of experience in the pharmaceutical...
The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?
India’s anaemia challenge is not simply about access to...
Newsletter
Get important news delivered directly to your inbox and stay connected!